Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
20
EVAX Quote, Financials, Valuation and Earnings
Last price:
$4.95
Seasonality move
:
-49.19%
Day range:
$4.70 - $5.00
52-week range:
$1.20 - $12.15
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.30x
P/B ratio:
1.74x
Volume:
23K
Avg. volume:
105.7K
1-year change:
9.97%
Market cap:
$31.1M
Revenue:
$3.3M
EPS (TTM):
-$6.99
Analysts' Opinion
-
Consensus RatingEvaxion AS has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $14.19, Evaxion AS has an estimated upside of 188.36% from its current price of $4.92.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $10.00 representing 100% downside risk from its current price of $4.92.
Fair Value
-
According to the consensus of 3 analysts, Evaxion AS has 188.36% upside to fair value with a price target of $14.19 per share.
EVAX vs. S&P 500
-
Over the past 5 trading days, Evaxion AS has underperformed the S&P 500 by -17.22% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Evaxion AS does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Evaxion AS revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Evaxion AS reported revenues of $37.5K.
Earnings Growth
-
Evaxion AS has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Evaxion AS reported earnings per share of -$1.01.
Enterprise value:
13.2M
EV / Invested capital:
--
Price / LTM sales:
3.30x
EV / EBIT:
--
EV / Revenue:
4.01x
PEG ratio (5yr expected):
-0.06x
EV / Free cash flow:
-0.49x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-69.51%
Net Income Margin (TTM):
-347.86%
Return On Equity:
--
Return On Invested Capital:
-238.97%
Operating Margin:
-57.38%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Income Statement | ||||||
| Revenue | -- | $278.4K | $3.2M | $153.9K | $37.5K | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$24.7M | -$19.1M | -$14M | -$4.6M | -$4.4M | |
| EBITDA | -$24.3M | -$15.2M | -- | -$6.2M | -- | |
| Diluted EPS | -$9.79 | -$4.60 | -$6.99 | -$1.14 | -$1.01 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $23.2M | $25.3M | $11.4M | $10.7M | $18.2M | |
| Total Assets | $27.7M | $34M | $16.8M | $15.2M | $22.4M | |
| Current Liabilities | $4.8M | -- | $4M | $3.8M | $5.3M | |
| Total Liabilities | $5.8M | -- | $14.2M | $14M | $16.2M | |
| Total Equity | $21.8M | $20.1M | $2.5M | $1.3M | $6.2M | |
| Total Debt | $1.1M | -- | $10.5M | $10.5M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2021-06-30 | 2022-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$18.7M | -$23.8M | -$7.5M | -$5.2M | |
| Cash From Investing | -- | -$1.1M | -$744K | -$494.2K | -$77K | |
| Cash From Financing | -- | $34.1M | $32M | -$20K | -$300K | |
| Free Cash Flow | -- | -$19.9M | -$24.6M | -$8M | -$5.3M | |
EVAX
Sector
Market Cap
$31.1M
$28.1M
Price % of 52-Week High
40.49%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.49%
1-Year Price Total Return
9.97%
-17.13%
Beta (5-Year)
--
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$5.56
200-day SMA
Buy
Level
$3.42
Bollinger Bands (100)
Buy
Level
3.11 - 6.43
Chaikin Money Flow
Sell
Level
-25.2M
20-day SMA
Sell
Level
$5.67
Relative Strength Index (RSI14)
Sell
Level
42.79
ADX Line
Sell
Level
15.93
Williams %R
Buy
Level
-86.2069
50-day SMA
Sell
Level
$5.99
MACD (12, 26)
Sell
Level
-0.11
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
197.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-16.2381)
Sell
CA Score
(Annual)
Level (-9.0389)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (9.7268)
Buy
Piotroski F Score
(Annual)
Level (5)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (0)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Evaxion AS engages in the discovery and development of immunotherapies for cancer and infectious diseases. Its technologies include the immuno-oncology platform PIONEER, the bacterial disease platform EDEN, the viral disease platform RAVEN, and the proprietary AI platform technology ObsERV. The company was founded by Niels Iversen Møller and Andreas Holm Mattsson on August 11, 2008 and is headquartered in Hoersholm, Denmark.
Stock Forecast FAQ
In the current month, EVAX has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EVAX average analyst price target in the past 3 months is $14.19.
-
Where Will Evaxion AS Stock Be In 1 Year?
According to analysts, the consensus estimate is that Evaxion AS share price will rise to $14.19 per share over the next 12 months.
-
What Do Analysts Say About Evaxion AS?
Analysts are divided on their view about Evaxion AS share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Evaxion AS is a Sell and believe this share price will drop from its current level to $10.00.
-
What Is Evaxion AS's Price Target?
The price target for Evaxion AS over the next 1-year time period is forecast to be $14.19 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is EVAX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Evaxion AS is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of EVAX?
You can purchase shares of Evaxion AS via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Evaxion AS shares.
-
What Is The Evaxion AS Share Price Today?
Evaxion AS was last trading at $4.95 per share. This represents the most recent stock quote for Evaxion AS. Yesterday, Evaxion AS closed at $4.92 per share.
-
How To Buy Evaxion AS Stock Online?
In order to purchase Evaxion AS stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get EVAX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EVAX
Sector
P/E ratio
--
23.89x
PEG ratio
-0.06x
-0.01x
P/B ratio
1.74x
1.81x
Price / LTM sales
3.30x
1.59x
Growth Metrics
EVAX
Sector
Revenue growth
-75.65%
4.62%
Earnings growth
15.55%
11.06%
Revenue (5-year growth)
--
6.5%
Earnings forecast
-$0.01
-$0.21
Profitability
EVAX
Sector
Profitability FY 2024
--
$3.6M
Return on invested capital
-238.97%
-31.84%
Return on assets
-69.51%
-27.96%
Return on equity
--
-37.63%
Earnings Date
Last Earnings Date
Dec
25
Next Earnings Date
Dec
25
Estimated Next Earnings Date
Mar
26
Balance Sheet
EVAX
Sector
Total cash
$14.7M
$26.4M
Short term investments
--
$25.7M
Total assets
$12.5M
$76.9M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
